| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |